Switching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: Results of a fifty-four

Switching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: Results of a fifty-four–week study

Published:2006 Issue:5 Volume:55 Page:812-816
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Cantini Fabrizio,Niccoli Laura,Benucci Maurizio,Chindamo Daniela,Nannini Carlotta,Olivieri Ignazio,Padula Angela,Salvarani Carlo

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference28 articles.

1. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

2. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial

3. Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: An open, observational, extension study of a three-month, randomized, placebo-controlled trial

4. Treatment of Ankylosing Spondylitis by Inhibition of Tumor Necrosis Factor α

5. Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expert Perspective: Management of the Psoriatic Arthritis Patient After Failure of One Tumor Necrosis Factor Inhibitor;Arthritis & Rheumatology;2023-05-24

2. Hidden in plain sight: Is there a crucial role for enthesitis assessment in the treatment and monitoring of axial spondyloarthritis?;Seminars in Arthritis and Rheumatism;2021-12

3. Head-to-Head Comparison of Etanercept vs. Adalimumab in the Treatment of Ankylosing Spondylitis: An Open-Label Randomized Controlled Crossover Clinical Trial;Frontiers in Medicine;2020-10-30

4. Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis;Mediators of Inflammation;2020-03-31

5. The Brazilian Society of Rheumatology guidelines for axial spondyloarthritis – 2019;Advances in Rheumatology;2020-02-21